AFT Pharmaceuticals (NZX: AFT)

Last close As at 21/12/2024

NZD2.80

0.00 (0.00%)

Market capitalisation

NZD294m

AFT Pharmaceuticals is a specialty pharmaceutical company that operates primarily in Australasia but has product distribution agreements across the globe. The company’s product portfolio includes prescription and over-the-counter (OTC) drugs to treat a range of conditions and a proprietary nebuliser.

Latest Insights

View More

Healthcare | Flash note

AFT Pharmaceuticals — H125 profitability weighed down by one-offs

Healthcare | Flash note

AFT Pharmaceuticals — Maxigesic IV reaches the Chinese shores

Healthcare | edison tv

AFT Pharmaceuticals – executive interview

AFT-Pharmaceuticals_resized

Sector

Healthcare

Equity Analyst

Arron Aatkar

Analyst

Jyoti Prakash

Jyoti Prakash

Analyst, Healthcare

Key Management

  • David Flacks

    Chairman

  • Dr Hartley Atkinson

    CEO

  • Malcolm Tubby

    Chief Financial Officer

  • Michael Weinmann

    Member of the Board of Directors

  • Nathan D. Hukill

    Member of the Board of Directors

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free